The iliac stent global market report 2024from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Iliac Stent Market, 2024report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The iliac stent market size has grown strongly in recent years. It will grow from $0.95 billion in 2023 to $1.02 billion in 2024 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to expansion of the global healthcare industry, increased awareness about minimally invasive procedures, increased demand for stenting procedures, rise in incidence of iliac artery diseases, improved healthcare infrastructure.
The iliac stent market size is expected to see strong growth in the next few years. It will grow to $1.34 billion in 2028 at a compound annual growth rate (CAGR) of 7%. The growth in the forecast period can be attributed to increasing prevalence of peripheral artery diseases, growing geriatric population, increasing angioplasty operations, rise in the need for less intrusive operations, rising incidence of diabetes. Major trends in the forecast period include technological advancements in iliac stents, increasing number of product approvals, advancements in medical technology, expanding distribution networks, adoption of iliac stents in outpatient settings.
Order your report now for swift delivery @ https://www.thebusinessresearchcompany.com/report/iliac-stent-global-market-report
Scope Of Iliac Stent Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Iliac Stent Market Overview
Market Drivers –
The increasing prevalence of peripheral artery diseases is expected to propel the growth of the iliac stent market going forward. Peripheral artery disease (PAD) is a circulatory condition characterized by the narrowing or blockage of arteries outside the heart and brain. The increasing prevalence of peripheral artery diseases is due to smoking, the aging population, hypertension, and diabetes. Iliac stenting is an effective treatment option for patients with PAD, offering improved blood flow, symptom relief, and prevention of complications while also being minimally invasive and associated with a high success rate. For instance, in July 2023, according to the Society For Cardiovascular Angiography And Interventions, a US-based organization, PAD affects 8-10 million Americans each year, and it is estimated that 19 million Americans will have PAD by 2050. Therefore, the increasing prevalence of peripheral artery diseases drives the iliac stent market.
Market Trends –
Major companies operating in the iliac stent market are developing innovative products such as iCast to improve patient outcomes and reduce the risk of complications. iCast-covered stent system represents an innovative approach to treating iliac artery occlusive disease, offering improved performance and reduced risk of complications compared to traditional bare-metal stents. For instance, in October 2023, Getinge, a Sweden-based healthcare company, announced the commercial availability of the iCast-covered stent system in the USA for treating iliac arterial occlusive disease approved by the Food and Drug Administration (FDA). This indication reflects Getinge’s commitment to bringing high-quality products and support to US clinicians and hospital systems to treat this severe condition.
The iliac stent market covered in this report is segmented –
1) By Type: Self-Expandable Stents, Balloon-Expandable Stents, Other Types
2) By Artery Lesions: Common Iliac Artery Lesions, Severe Calcified Lesions, Complete Obstructive Lesions
3) By End-Users: Hospitals, Outpatient Facilities, Other End-Users
Get an inside scoop of the iliac stent market, Request now for Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=15827&type=smp
Regional Insights –
North America was the largest region in the iliac stent market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the iliac stent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Key Companies –
Major companies operating in the iliac stent market are Cardinal Health Inc., Abbott Laboratories, Medtronic Plc, Becton, Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, W. L. Gore & Associates Inc, C. R. Bard Inc., Getinge AB, Cook Medical LLC, Biotronik SE & Co. KG, MicroPort Scientific Corporation, Cordis Corporation, Endologix Inc., LeMaitre Vascular Inc., Alvimedica, Clearstream Technologies Ltd., Jotec GmbH, Translumina GmbH, Vascular Concepts Limited, Lombard Medical Technologies , Acandis GmbH, Gore Medical, Medizintechnik GmbH
Table of Contents
1. Executive Summary
2. Iliac Stent Market Report Structure
3. Iliac Stent Market Trends And Strategies
4. Iliac Stent Market – Macro Economic Scenario5. Iliac Stent Market Size And Growth
…..
27. Iliac Stent Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Explore the trending research reports from TBRC:
https://topprnews.com/non-proliferative-diabetic-retinopathy-market-outlook/
https://topprnews.com/point-of-care-poc-coagulation-testing-devices-market-trends/
https://topprnews.com/global-quantum-key-distribution-market-analysis/
https://goodprnews.com/non-proliferative-diabetic-retinopathy-market-outlook/
https://goodprnews.com/point-of-care-poc-coagulation-testing-devices-market-size/
https://goodprnews.com/quantum-key-distribution-market-analysis/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
